510(k) Report

FDA product code · Hematology

Centrifuge, Blood-Bank For In Vitro Diagnostic Use

KSOClass I21 CFR 864.9275510(k) exempt1 decision since 19780 recalls

FDA lists KSO as exempt from 510(k): a device of this type needs no clearance unless one of the limits in 21 CFR 864.9 applies, such as a new intended use or a different fundamental technology. 1 FDA decision since 1978. No recall names this code.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026 Download the data (CSV)

FIG. A — Illustration, hematology panel

Twenty years of KSO at a glance: how often FDA decides these devices, how long 510(k) reviews take, how often they are recalled, and how many adverse event reports name the code.

FDA decisions per year · KSO

FDA has decided no KSO device since 2007.

Median 510(k) review, days · KSO

Too few KSO 510(k)s in any year since 2007 to give a median.

Recalls per year · KSO

No recall names KSO since 2007.

Adverse event reports per year · KSO

2in 2009

2007: 32008: 52009: 2
2007high 5 (2008) · low 0 (2010)2025

MAUDE reports naming product code KSO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—03
20080—05
20090—02
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—
FIG. 1 — KSO by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports, MAUDE · Data through Oct 25, 2026

Planning a device in KSO? A 510(k) Report ranks candidate predicates in this code by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report